Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro.
about
Cholera toxin: a paradigm of a multifunctional proteinOral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice.Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.Inhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunitIntranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissueIntranasal immunization confers protection against murine Pneumocystis carinii lung infectionFacilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines.Anti-class II monoclonal antibody-targeted Vibrio cholerae TcpA pilin: modulation of serologic response, epitope specificity, and isotypeCholera toxin - a foe & a friend.Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines.Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA.Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.Activated human nasal epithelial cells modulate specific antibody response against bacterial or viral antigens.Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functionsCholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells.Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.Production of polyclonal antibodies to the trichothecene mycotoxin 4,15-diacetylnivalenol with the carrier-adjuvant cholera toxin.Induction of cytokines in phagocytic mammalian cells infected with virulent and avirulent Listeria strains.Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice.Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine productionGeneration of antibodies reactive with fumonisins B1, B2, and B3 by using cholera toxin as the carrier-adjuvant.Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection.Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression.Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticityA nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and lps genes.Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunitPromotion of colonization and virulence by cholera toxin is dependent on neutrophils.Mechanisms of Cholera Toxin in the Modulation of TH17 Responses.Heat-labile enterotoxins as adjuvants or anti-inflammatory agents.Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells.Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.The Type II heat-labile enterotoxins LT-IIa and LT-IIb and their respective B pentamers differentially induce and regulate cytokine production in human monocytic cells.Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines.Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins.Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity.
P2860
Q24598726-6A0D27D8-3CAF-474A-9F5F-C3C03F079E70Q33597025-DCA12FC6-5EB2-473F-80AF-2D9F9E6F3941Q33676552-31D77E41-23A6-4199-8AEF-A51190C50D22Q33757092-D217C47B-29AA-4EC2-92EA-13FC59240A53Q33769366-9A760E28-AB34-4593-8EC4-0B521EC87873Q34000349-E57F4296-379E-481B-9544-EDEDDAB20EA5Q34008465-167867A2-6769-4018-9014-B39F64BBCD36Q34009811-084E43DC-92AD-4259-81AE-4BEF99C90C4DQ34026162-DA885374-70EA-410E-B7CA-46F2EACA8156Q34520511-280BDC84-3B1B-4F1A-A413-925CA913D433Q34522227-2A0DBAE2-5CDE-4610-9733-F3A465A29D53Q34522325-F34CC180-F27A-495B-A54C-652B933CA1B0Q34537687-60D092DC-B1A4-4B91-9E94-4551C7B28CC3Q34545284-8E5FB78E-9588-497F-AEAE-2FE822743200Q34584253-82FBE25A-DF8E-44A6-9EFA-68BFC36D95AAQ34715639-9E701243-F737-4ADC-A110-0F4253FF503AQ34739851-000052A1-703F-4386-9AAF-94A212AF113DQ35545804-5CC90694-9091-4F4C-85F9-1D89D5E0DE54Q35551202-D7438023-CEF7-40E8-B5FD-5FD588900314Q35676915-B5C250DF-BBE5-483D-9C1B-FFE58BABA740Q35772286-8DA9657A-D298-4254-B528-CD158ABE1F28Q35802657-CB488316-7433-40D8-9D72-42C68F5280A3Q35802766-3F8050BA-BD6E-4151-B82B-13366335973CQ35949369-BA6ED281-85E4-49B0-9745-4968050D220AQ36211171-7F0CA8D8-824F-4E89-8FAD-28A51613CEBBQ36367736-1170CFE3-D59D-4E10-AA2A-8474688FEBB0Q36377098-5BFE7C0C-C925-4D82-9CE8-8AE30A5D830BQ36770993-77C943E5-4ED5-46D2-B38C-DD9E1BC7C39FQ36947860-45D5B1A1-C58B-4B63-A519-E3AEEBEE2008Q36989025-38F4C953-54EA-4AEC-9BBA-1660233CCA3FQ37123707-3E3D7A4E-8F6F-410F-AA34-15AA84A8BE29Q37641941-F6810CEF-7FE7-4C8E-8FA0-32C8A34C6404Q37749719-8F5F63E1-9143-4B65-A377-DEEA04DB3610Q39522002-17BD5A38-EF24-4784-A7FD-13A73741D140Q39741614-1D5C8E6D-6316-4AAC-9BB8-8D819BE5DE16Q40205845-6DD303A0-71D3-4FCF-9B7F-9311F08E6D8FQ40269379-A2FD7E83-C8ED-4357-AE32-D1A3D2C63298Q40374294-4787BAAD-B690-4E5B-A937-0CF34A097DF4Q41850548-985CC915-6D69-42B1-9E36-051E8ACD17A0Q41855397-D1C03BE5-C4B8-4219-96AB-9DD17301A919
P2860
Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Cholera toxin stimulates IL-1 ...... ation by macrophages in vitro.
@en
type
label
Cholera toxin stimulates IL-1 ...... ation by macrophages in vitro.
@en
prefLabel
Cholera toxin stimulates IL-1 ...... ation by macrophages in vitro.
@en
P1476
Cholera toxin stimulates IL-1 ...... tation by macrophages in vitro
@en
P2093
Bromander A
P304
P407
P577
1991-05-01T00:00:00Z